Sign In
Buy NTRA
$234.76
+5.96 (+2.60%)
At Close: Jun 23, 2026
Castleark Management LLC Has $5.87 Million Stake in Natera, Inc. $NTRA
03:54am, Monday, 15'th Dec 2025
Castleark Management LLC lessened its position in Natera, Inc. (NASDAQ: NTRA) by 19.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Co
Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer
08:00am, Friday, 12'th Dec 2025
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and MEDSIR (Medica Scientia Innovation Research), a global leader in oncology rese
Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks
09:11am, Thursday, 11'th Dec 2025
Stanley Druckenmiller is a Wall Street legend whose trades are truly worth tracking due to how consistently he has been winning.
Baird Financial Group Inc. Has $4.50 Million Stock Holdings in Natera, Inc. $NTRA
05:46am, Thursday, 11'th Dec 2025
Baird Financial Group Inc. increased its holdings in shares of Natera, Inc. (NASDAQ: NTRA) by 277.8% during the undefined quarter, according to the company in its most recent 13F filing with the SEC.
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, together with Alliance Foundation Trials, LLC (AFT) and the Austrian Breast and Co
Natera Highlights New Findings in Lymphoma at the ASH Annual Meeting
08:00am, Tuesday, 09'th Dec 2025
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today shared the results from two oral presentations that were presented at the Am
Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal?
01:33pm, Friday, 05'th Dec 2025
Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stock is trading lower on Friday, despite no company-specific news, likely reacting to Natera Inc.'s (NASDAQ: NTRA) acquisition of cancer diagnostic
Natera Acquires Foresight Diagnostics
07:00am, Friday, 05'th Dec 2025
AUSTIN, Texas & BOULDER, Colo.--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and Foresight Diagnostics, a leader in ultrasensitive molecular r
Edgestream Partners L.P. Grows Stock Position in Natera, Inc. $NTRA
04:38am, Thursday, 04'th Dec 2025
Edgestream Partners L.P. lifted its position in Natera, Inc. (NASDAQ: NTRA) by 154.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissio
New Signatera™ Data in Lymphoma and Multiple Myeloma to be Presented at the 2025 American Society of Hematology Annual Meeting
08:00am, Wednesday, 03'rd Dec 2025
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, announced that new data on Signatera will be presented at the 2025 American Societ
Natera to Present 12 Datasets Including >50,000 Patients Featuring Signatera™ at the San Antonio Breast Cancer Symposium
08:00am, Tuesday, 02'nd Dec 2025
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that at least twelve abstracts highlighting Signatera will be shar
30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks
03:14am, Sunday, 30'th Nov 2025
Druckenmiller invests his personal and family's wealth through his fund, the Duquesne Family Office. Druckenmiller is high on biotech stocks, with his top three holdings at the end of the third quarte
Coldstream Capital Management Inc. Acquires 427 Shares of Natera, Inc. $NTRA
04:20am, Friday, 28'th Nov 2025
Coldstream Capital Management Inc. increased its holdings in Natera, Inc. (NASDAQ: NTRA) by 17.6% during the second quarter, according to the company in its most recent 13F filing with the Securities
Creative Planning Grows Stock Holdings in Natera, Inc. $NTRA
04:02am, Thursday, 27'th Nov 2025
Creative Planning increased its holdings in shares of Natera, Inc. (NASDAQ: NTRA) by 29.2% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and
This Investor Beat the Market for 3 Decades Without a Single Losing Year. 3 Stocks He's Buying Now.
11:38am, Monday, 24'th Nov 2025
Stanley Druckenmiller has been one of the most successful investors, a billionaire with a long record of high returns in global macro investing.
